Importantly, this hypoxia-induced PD-L1 upregulation was largely, while not totally, diminished by ATXN3 targeted deletion (Figure 3, A and B), implying a possibility that ATXN3 enhances hypoxia-induced PD-L1 expression in tumor cells. The gene discussed is CD274; the disease is neoplasm.